tiprankstipranks
Erasca announces IND clearance, prioritizing of RAS-targeting franchise
PremiumThe FlyErasca announces IND clearance, prioritizing of RAS-targeting franchise
2M ago
Erasca’s Innovative RAS/MAPK Pathway Targeting and Promising Preclinical Data Earns Buy Rating
Premium
Ratings
Erasca’s Innovative RAS/MAPK Pathway Targeting and Promising Preclinical Data Earns Buy Rating
2M ago
Erasca presents new RAS-targeting franchise data at AACR meeting
Premium
The Fly
Erasca presents new RAS-targeting franchise data at AACR meeting
2M ago
Erasca, Inc. Reports Strong Progress in Oncology Pipeline
PremiumCompany AnnouncementsErasca, Inc. Reports Strong Progress in Oncology Pipeline
8M ago
Erasca reports Q3 EPS (11c), consensus (17c)
Premium
The Fly
Erasca reports Q3 EPS (11c), consensus (17c)
8M ago
Erasca announces clinical progress for naporafenib
Premium
The Fly
Erasca announces clinical progress for naporafenib
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100